chrisvoncsefalvay/vaers-outcomes huggingface dataset:
cough; achy; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of COUGH (cough) and PAIN (achy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced COUGH (cough) and PAIN (achy). At the time of the report, COUGH (cough) and PAIN (achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment information provided    Reporter did not allow further contact
On January 5th 2022 I began having a sore throat and runny nose. On January 6th I began to run a fever and had body aches and chills, I also tested positive with COVID 19 on a home test. My fever was about 101F for about 3-4 days. The body aches and chills left when the fever did. I stayed in bed for about a week and a half with great fatigue. I did not seek medical care, just my primary care physician over text. I took Mucinex DM. I took Tylenol and drank a lot of fluids. I fully recovered after about 4 weeks.
This case was received from a health professional on 03 September 2008. This case represents on in a cluster of two patients. A four-year-old male patient received the following vaccines on 29 August 2008: an intramuscular right thigh, fourth injection of IPOL (lot number A0491), intramuscular right thigh fifth injection of TRIPEDIA (lot number U2356CA), MMR (Merck, lot number not reported), and VARICELLA (Merck, lot number not reported). On 01 September 2008, he developed a temperature of 103.2 degrees Fahrenheit, lasting 48 hours. No other symptoms were reported, and the patient recovered. Follow-up information was received 29 September 2008 from a health care professional. The patient had no illness at the time of vaccination. The MMR and VARICELLA vaccines received by the patient had been a firs dose of MMR lot number 0425U, and a first dose of VARICELLA lot number 0514X (routes and sites not reported. The reporter in this case also reported a similar adverse reaction in another patient; that event is captured in case number 2008-02800.
Pt recvd booster dose of Hep B vax on 5FEB91-Pt had recvd 2 prev series of Hep B in 1983 & 1987, & on 7FEB91 exp severe muscle weakness & myalgia in back, neck, arms, & shoulders; Also exp malaise & arthralgia that worsened over 1-2 wk per;
kidney stones; infection; This is a spontaneous report received from a Pfizer-sponsored program.  A 51-year-old male patient (husband) received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown), single dose, dose 1 via an unspecified route of administration on an unspecified date for COVID--19 immunisation. The patient's medical history was not reported. The patient's concomitant medications were not reported. The patient was in the hospital for treatment of kidney stones on an unspecified date. Kidney stone symptoms started after his first dose. On an unknown date, he had a stent placed and had an infection. Treatment was received for kidney stones.The clinical outcome of kidney stones was unknown.  Information about the Lot/batch number has been requested.
Tinnitus in left ear. started shortly after 2nd covid shot. it rings 24/7 very loud. never had it prior to covid vaccine.
Swelling, warmth, tenderness, Erythema 11x13cm at times of exam which is "slightly better" than the past 24 hours.
I am thinking that I might have had something before. This summer, I was very thirsty and dehydrated. This time, I was thirsty. I had tingling in my face and basically the rest of my body. Then on 11/28/2021 ? I had pain in my jaw which still hasn't gone away. Then I had some discomfort in my chest, some lightheadedness and dizziness but no fainting. My teeth felt uncomfortable and felt like they were going to fall out. Discomfort in all of my teeth.
Vaccine exp. on 09/19/2021.  Vaccine was given on 09/21/2021.
From initial information received on 29/Dec/2003 from a registered nurse regarding an adverse event occurring in the USA, it was reported through a telephone call regarding a VAERS report involving seven children that a child, age and gender not reported, received a dose of TD ADS adult, no other vaccine information provided, on an unspecified date. Approximately ten minutes later, the patient developed generalized reddened rash, dizziness and nausea. The symptoms lasted several hours and by the time the child saw the PMD, they were gone. Reportedly, the patient recovered from these events. In the opinion of this public health nurse, she felt that two of the seven cases requiring reporting. The nurse stated that reports were submitted to VAERS, but because she did not keep copies, she was unable to provide patient identifying information at this time. The reporter (HCP) promised to follow-up and fax completed VAERS forms to manufacturer by 07/Jan/2004. No other information was provided at this time. The reporter of this case is the same reporter of case 2003-00995.
Got the vaccine still got shingles/suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the vaccine still got shingles/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient relative via interactive digital media. The reporter reported that his or her mother received Shingles vaccine and experienced shingles. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Rash on arm by immunization site. Nausea, fever, headache and light sensitivity.
This spontaneous report was received from a nurse regarding multiple patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (lot # L048236, expiry date 31-MAR-2018) (dose and route of administration were not reported). Administered doses of vaccines experienced the temperature excursion of -0.17 degrees Celsius for 1 hour 15 minutes. There was no adverse effect reported. Data logger was involved. There were no previous excursions reported. This report is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a nurse practitioner concerning a female who on 29-JUL-2008 was vaccinated with the first dose of GARDASIL (lot n. 660389/1668U) 0.5 mL intramuscularly. On 26-SEP-2008. On 26-SEP-2008, the patient was vaccinated with a second dose of GARDASIL (Lot n. unspecified). There was no concomitant medication. Nurse practitioner reported that after dose 1 of GARDASIL, the patient hasn't had any periods. The patient has been diagnosed with amenorrhea. The patient saught unspecified medical attention. The patient's last normal cycle was on 16-JUL-2008. At time of reporting the patient had not recovered. Additional information has been requested.
Patient received Pfizer as her 2nd COVID shot--she got Moderna as her 1st
I contracted Covid-19 a week after receiving the first dose of the vaccine. I had all symptoms of the disease after the vaccine except for a fever and then I got tested and was positive. I got the second dose of the vaccine 23 days after testing positive with Covid-19. I started having Heart Palpitations three days after the second shot. Six days after the shot I started to have a high heart rate. It was 111-132 resting intermittently throughout the day. It is still doing that after 10 weeks and I am scheduled to be put on a heart monitor this week. I sometimes had shortness of breath when I was having Palpitations. I have a normal heart rate of 52-58 . My doctor is unsure whether it is a symptom of Covid-19 or from the vaccine. After twelve weeks the symptoms have been consistent since they started.
I had a breakthrough case of Covid-19 symptoms, started Monday, tested positive Wednesday felt like I had a cold.
The patient stated she felt hot as soon as the immunization was administered. She stated she felt weak and hot. About 5 minutes after the shot was given, she slumped over as if she passed out. I checked her pulse. She had a pulse. About 30 seconds after that, she started shaking. The seizure lasted approximately 1 minute. She eventually became alert (about 1 minute after seizing stopped. She began talking and remained seated for about 5 minutes. She then stopped talking and blinking. She was having a different type of seizure (petit mal). Paramedics arrived, but the patient refused treatment. She stated she frequently has seizures.
Spike in blood pressure, dizzy, narrowing of vision. Paramedics were called, but patient recovered after a few minutes. Husband was called and left the facility with him.
hypernosmia/Strong Sense of Smell; dizziness; euphoric feeling; fatigue; fever; Uncontrolled restless leg; This spontaneous case was reported by a consumer and describes the occurrence of EUPHORIC MOOD (euphoric feeling), FATIGUE (fatigue), PYREXIA (fever), DIZZINESS (dizziness) and PAROSMIA (hypernosmia/Strong Sense of Smell) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A12A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Restless legs syndrome. Concomitant products included CLONAZEPAM (KLONOPIN), ROPINIROLE and TRAZODONE for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 02-Mar-2021, the patient experienced EUPHORIC MOOD (euphoric feeling), FATIGUE (fatigue) and PYREXIA (fever). In March 2021, the patient experienced RESTLESS LEGS SYNDROME (Uncontrolled restless leg). On 04-Apr-2021, the patient experienced DIZZINESS (dizziness). On an unknown date, the patient experienced PAROSMIA (hypernosmia/Strong Sense of Smell). On 02-Mar-2021, EUPHORIC MOOD (euphoric feeling) had resolved. On 03-Mar-2021, FATIGUE (fatigue) had resolved. At the time of the report, PYREXIA (fever), DIZZINESS (dizziness) and PAROSMIA (hypernosmia/Strong Sense of Smell) outcome was unknown and RESTLESS LEGS SYNDROME (Uncontrolled restless leg) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Mar-2021, Body temperature: 103.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment provided with Celecoxib, Unspecified Opioid, Valerian drops, passion flower and black cherry.
Slight discomfort, "weird" on Thurs. Was on leave and going to B&B, felt sick on Fri - nausea, LH, malaise, pain/erythema/warmth RUE. Returned home early from vacation on Sat, went to military health same day and was given Septra DS 1 tab po daily (not bid) and has been taking since then. Still not feeling well.
Information has been received from a licensed practical nurse, concerning a 60 year old male patient, who on 19-SEP-2007 was vaccinated IM in the left arm with a dose, 0.5 ml, of PNEUMOVAX 23 (lot # 657525/0554U). Concomitant vaccine therapy at the visit included a dose in the left arm of FLUZONE. The following day, 20-SEP-2007, the patient called the office with symptoms of cellulitis, including redness and soreness at the injection site, and chills. Treatment with DURICEF was prescribed. The patient had a return visit scheduled to the physician on 22-SEP-2007 (future date). At the time of this report, the patient had not recovered. This is one of two reports received from the same source (WAES #0709USA03696) following vaccination with PNEUMOMAX 23 (lot #657585/0554U). The nurse a lot check. The records of testing prior to release of the lot in question, have been rechecked and found to be satisfactory. The lot complies with the standards of Center for Biologics Evaluation and Research, and was released. Additional information has been requested.
Unsure if related to vaccine but timing is very suspect. I am 25 years old and in good health but developed Shingles on 4/17/2021  (diagnosed at the emergency room on 4/20). Due to the very low likelihood of shingles at the age of 25 and my good health history I figured it could be worth a submission / a data point in the event others are experiencing the same.
I experienced body aches, short of breath, cold sweats, fever, headaches, severe diarrhea, lack of concentration, lack of sleep, and night sweats.
Woke up following day after receiving 2nd dose of Pfizer COVID vaccine with shortness of breath.  Took my inhaler and it resolved.
When administered the shot was difficult to inject so the student asked the instructor what to do and the instructor said push harder. She proceeded and it was very painful. Days after the shot when normal pain should have subsided my arm still hurt. Reaching behind my back is difficult and my range of motion is decreased. I also have some tingling in my arm and overall soreness.  I have some weakness in the arm. I wake up at night in pain. I have been taking Advil and have been prescribed a topical anti-inflammatory medicine.
This spontaneous report as received from a medical assistant refers to a 6 month 10 days old infant patient. The patient's pertinent medical history, current conditions and concomitant medications were not reported. On an unknown date the patient was vaccinated with first dose of ROTATEQ in immunization series (lot # L035637, with expiry date: 09-JUN-2017 which is outside recommended schedule. No adverse effects were reported. Additional information has been requested.
cellulitis at injection site 2 days, fever. Tx AUGMENTIN 500mg bid x 10d.
Patient was given a vaccine that had expired one day earlier on 7/13/2022.  No adverse event occurred from being given this vaccine.
NAUSEA, TINGLING SENSATION ALL OVER --->@1233 TINGLING IN TOES Narrative:
pt recv vax 13NOV95 & devel mild redness & tenderness @ inj site which was treated w/ASA;no other details were available as of the reporting date;
Patient presents same day to discuss possible reaction to shingles vaccination 6/21.  Notes initial soreness, achiness, and rash to L arm injection site near deltoid.  Somewhat less red today.  Denies any weakness, streaks, fever, chills, chest tightness, wheezing, airway compromise.  No history of respiratory disease.  As needed OTC Tylenol has provided benefit.  She is asking for guidance on her second vaccine in 2 months.  She does report mild zoster in her 40s.
ACUTE RESPIRATORY FAILURE 2/24/2023 ESOPHAGEAL CANCER, UNSPECIFIED SITE ACUTE RESPIRATORY FAILURE 2/24/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA ACUTE RESPIRATORY FAILURE 2/24/2023 CAD (CORONARY ARTERY DISEASE) WO ANGINA ACUTE RESPIRATORY FAILURE 2/24/2023 BRCA1 GENE MUTATION POSITIVE
last fall I took the Shingrix shots / Four weeks ago I came down with shingles/ suspected vaccination failure; shingles; terribly painful; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. In February 2021, less than 6 months after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix. It was unknown if the reporter considered the pain to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. Last fall the patient received the Shingrix vaccine, as physician and everyone said the patient need to get them. Four weeks before the date of reporting, the patient came down with shingles, that was terribly painful, and it was still painful. The patient was very disappointed with the results patient have had, it's so painful. The patient stated that patient had to pay full price for shots out of pocket 100 percent and know it was not 100 percent but 96 percent. This case was considered to be a suspected vaccination failure case, as the details regarding laboratory confirmation for shingles was unknown.
Initial report received from a health care professional on 23 Dec 2009: This 18 months old child was vaccinated with S-OIV FLUVIRIN (batch no. 1013293P) on 22 Dec 2009. The vaccine was inadvertently given to the patient below age of 4 years. No adverse event was reported after vaccination.
Violent tremor for about 10 minutes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 05Jun2021 10:30 (Lot number: Gw0180) at the age of 51 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: MOTRIN [IBUPROFEN]; TYLENOL; OMEPRAZOLE. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer, lot number=EW0182, lot unknown=False, administration date=15May2021, administration time=10:15 AM , dose number=1, vaccine location=left arm), administration date: 15May2021, when the patient was 51 years old, for Covid-19 immunization. The following information was reported: TREMOR (non-serious) with onset 06Jun2021 03:00, outcome "recovered", described as "Violent tremor for about 10 minutes". Therapeutic measures were not taken as a result of tremor. Additional information: The patient did not reported Covid prior to vaccination and did not tested for covid post vaccination. The patient did not had any allergies. No other vaccine in four weeks.  Follow-Up (19Jul2021): No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a healthcare professional and refers to a currently 13 months old, female patient. The patient's medical history and concurrent conditions were not reported. On 12-NOV-2015, the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX lot # L008270 with expiration date 11-MAR-2017 (dose, and route of administration were not provided). No concomitant medications were reported. No adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected as all scheduled follow up information was received.
shingles devel (lt leg) 19DEC97;pt twin vaccinated same day;
Pt seen in at student Health Services for right upper arm swelling (5cm), pain and redness, S/P Tdap and Pneumococcal injection on 05/11/12.
Severe headache; body ache; This is a spontaneous report from a non-contactable consumer, the patient. A 55-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EP6955) via an unspecified route of administration in the arm left on 26Apr2021 at 11:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was not provided. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sucralfate (MANUFACTURER UNKNOWN) and dexlansoprazole (DEXILANT) all for unknown indication from unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EP6955) via an unspecified route of administration in the arm left on 05Apr2021 at 11:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. On 26Apr2021 the patient experienced severe headache and body ache. Therapeutic measures were not taken as a result of the events. On an unknown date in Feb2021, the patient underwent SARS-CoV2 test and the result was negative. The clinical outcome of the events severe headache and body ache were unknown at the time of this report.    No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a medical assistant refers to a patient of an unknown age and gender. The patient's concurrent conditions and medical history were not reported. On an unknown date, the patient could have been vaccinated with VARIVAX lot # M045204, expiration date 11-NOV-2018 or PROQUAD lot # M043310, expiration date 24-APR-2018 albumin status rHA or lot # M047303, expiration date 29-MAY-2018, albumin status rHA or lot # M048201, expiration date 05-JUN-2018, albumin status rHA; lot # N000336, expiration date 03-JUL-2018, albumin status rHA or with M-M-R II lot# L026551, expiration date 16-JUL-2017 albumin status HSA or lot # M035935, expiration date 09-AUG-2018, albumin status HSA (dose, route of administration and frequency were not provided for all vaccines). Vaccines were reconstituted with properly stored MERCK STERILE DILUENT. The temperature excursions were not reported for PROQUAD lot # M043310. All other vaccines underwent following temperature excursions: from - 0.9 to 10.6 degrees Farenheit on 02-MAY-2017 for over 38 hours, from -0.4 to 9.6 degrees Farenheit on 03-MAY-2017 for 38 hrs; from -0.9 to 8.1 on 09-MAY-2017 and from -5.6 to 7 on 10-MAY-2017 for 37 hrs; from -5.3 to 6.3 on 15-MAY-2017 for 31.5 hrs; from -6.2 to 8.2 on 19-MAY-2017 for 15 hrs; from -7.1 to 7.2 on 22-MAY-2017 and from -6.5 to 6.4 on 23-MAY-2017 for 64 hrs; from -6.2 to 9.5 on 25-MAY-2017 for 14 hrs; from -7.1 to 6.6 on 30-MAY-2017 for 86hrs. The reporter said that the patient may have received one of the improperly stored suspect therapies, but the reporter was not sure which one. There was no previous temperature excursion. The call was made because of a data logger. No adverse effect was reported. Additional information has been requested.